Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
RSB Spine, LLC v. DePuy Synthes Sales, Inc., et al.
Case Number:
1:19-cv-01515
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
November 18, 2025
J&J Unit Fights $12M Verdict While Rival Wants More Money
A Delaware federal jury was wrong when it determined that Johnson & Johnson subsidiary DePuy Synthes should pay RSB Spine $12 million for infringing spinal fusion patents under the doctrine of equivalents, DePuy said Monday.
-
August 28, 2025
Del. Judge Rejects J&J Unit's $12M Interference Claim
Johnson & Johnson unit DePuy Synthes Sales Inc. could not persuade a Delaware federal judge that it invented the technology behind an RSB Spine LLC spinal fusion surgery patent a jury says it owes $12 million for infringing.
-
December 09, 2022
J&J Unit Hit With $12M Verdict In Spinal Implant IP Suit
A Delaware federal jury on Friday found that Johnson & Johnson unit DePuy Synthes Sales Inc. infringed a spinal fusion surgery patent under the doctrine of equivalents and owed $12 million to RSB Spine LLC.
-
November 22, 2022
J&J Unit Invalidates Spinal Implant Patent On Eve Of Trial
A Delaware federal judge Tuesday invalidated one of the two spinal fusion surgery patents that Johnson & Johnson unit DePuy Synthes Sales Inc. is accused of infringing less than two weeks before the scheduled start of a trial.